Study 111-104 Recruiting
A Phase 1, Randomized, Open-Label, Sponsor-Open, Two-Sequence, 两期交叉研究:在健康成人受试者中,用小瓶和注射器或注射笔给药单次皮下剂量BMN 111的生物等效性
Indication
Achondroplasia
Goal
研究在健康成人受试者中使用小瓶和注射器或注射笔给药的单次皮下剂量bmn111的生物等效性
Investigational therapeutic
联合产品:BMN111注射剂给药, Drug: BMN111 administration via vial and syringe
Status
This study is currently recruiting participants
Study Type
Phase 1